Mirae Asset Global Investments Co., Ltd. Tyra Biosciences, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,054 shares of TYRA stock, worth $29,310. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,054
Previous 1,693
21.32%
Holding current value
$29,310
Previous $15,000
26.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TYRA
# of Institutions
122Shares Held
59.8MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA12.2MShares$174 Million2.55% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$58.2 Million93.82% of portfolio
-
Nextech Invest Ag4.06MShares$57.9 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$57.9 Million7.35% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$56.3 Million1.48% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $599M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...